Health TrialsbyHealthPanel

Clinical Study to Evaluate the Body Fat Reducing Effects of Heat-Treated Green Tea Extract Complex

ConditionBody Fat
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-64
SponsorAmorepacific Corporation

About this trial

This clinical study was designed to evaluate the efficacy and safety of body fat reduction in obese adults by treatment of heat-treated green tea extract complex

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

lt;>

Males and females aged between 19 ~ 64 years

BMI 25.0 ~ 34.9 kg/m²

Waist circumferebce: 90cm or more for men, 85cm or more for women

Disqualifiers

Participants whose weight changed by more than 10% within the 3 months prior to visit 1

Individuals participated in a commercial weight loss program within 3 months prior to Visit 1

Participants who have undergone surgical procedures within 3 years

Participants who have taken obesity treatment medications within the last 3 months

Trial design

Design model

Parallel

Treatments tested in this trial

  • HTGT compound

    Dietary supplement

    oral administration of HTGT compound once daily

  • Placebo

    Dietary supplement

    Oral administration of placebo once daily

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: HTGT compoundExperimental treatment 1 intervention
Group B: PlaceboPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change of body fat by DEXA

Measurement was made by using dual-energy X-ray absorption(DEXA)

Time frame
Baseline, Week 12

Secondary outcomes

1

Changes of total abdominal fat area, visceral fat area and subcutaneous fat area

Measurement of the target area is made using computed tomography

Time frame
Baseline, Week 12
2

Changes of indicator of lipid metabolism

indicator of lipid metabolism (i.e., TC, TG, HDL, LDL)

Time frame
Baseline, Week 12
3

Changes of waist circumference

Measurement of waist circumfernece was performed in accordance with WHO guideline

Time frame
Baseline, Week 12
4

Changes of blood biomarker

adiponectin, etc.

Time frame
Baseline, Week 12

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Amorepacific Corporation

Lead sponsor

Source ClinicalTrials.gov
Apply now